PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Barbara J. Ring(Eli Lilly (United States)), Jenny Y. Chien(Eli Lilly (United States)), Kimberly K. Adkison(Research Triangle Park Foundation), Hannah M. Jones(Pfizer (United Kingdom)), Malcolm Rowland(University of Manchester), Rhys D.O. Jones(AstraZeneca (United Kingdom)), James Yates(AstraZeneca (United Kingdom)), M. Sherry Ku, Christopher R. Gibson(United States Military Academy), Handan He(Novartis (United States)), Ragini Vuppugalla(Bristol-Myers Squibb (United States)), Punit Marathe(Bristol-Myers Squibb (United States)), Volker Fischer(Abbott (United States)), Sandeep Dutta, Vikash K. Sinha(Janssen (Belgium)), Thorir D. Bjornsson(Critical Path Institute), Thierry Lavé(Roche (Switzerland)), Patrick Poulin
Journal of Pharmaceutical Sciences
May 3, 2011
Cited by 200

Abstract


Related Papers

No related papers found

Powered by citation graph analysis